{
    "nctId": "NCT03847623",
    "briefTitle": "Effect of Preoperative Curcumin in Breast Cancer Patients",
    "officialTitle": "Effect of Preoperative Curcumin in Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Tumour infiltrating lymphocytes (TILs)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with operable breast cancer\n* Life expectancy of at least 3 months\n* Adequate organ function\n* No allergy to curcumin\n* Provides consent to participate in trial and adhere to the study protocol\n\nExclusion Criteria:\n\n* Receiving concomitant radiotherapy, hormonal, immune therapy or other investigational drugs\n* Uncontrolled concurrent illness\n* Patient of anti platelet medications\n* Pregnant / breast feeding\n* Patients who are unable or unwilling to take curcumin, herbal remedies, or non-prescription medications\n* Patients with bleeding tendency, bleeding disorders and abnormal bleeding/clotting profile",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}